Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Dose Finding Study of Different MOD-4023 Dose Levels Compared to Daily R-human Growth Hormone (hGH) Therapy in Pre-pubertal Growth Hormone Deficient Children

NCT02500316 is registered in ClinicalTrials.gov with OPKO Health, Inc. as lead sponsor.

NCT NCT02500316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02500316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Dose Finding Study of Different MOD-4023 Dose Levels Compared to Daily R-human Growth Hormone (hGH) Therapy in Pre-pubertal Growth Hormone Deficient Children
Lead sponsor
OPKO Health, Inc.
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2014
Completion date
November 30, 2023
Enrollment
48 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone deficiency (ghd)